直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Seminar

Protecting Intellectual Property in Pharmaceuticals

September 26, 2019

Cambridge, Massachussetts

Northeastern Section of American Chemical Society (NESACS)

Biogen, Inc.

Finnegan is a sponsor of the Northeastern Section of the American Chemical Society (NESACS) September Board Meeting. Finnegan attorney Sara Leiman will join the panel discussion, “Protecting Intellectual Property in Pharmaceuticals,” focusing on considerations and strategies toward protecting intellectual property in pharma and biotech.  Sofia Santos will moderate the discussion. The program will take place at Biogen in Cambridge, Massachusetts. For more information, or to register, please see NESAC’s website.

Related Industries

Life Sciences

Pharmaceutical

Related Professionals

Sara A. Leiman, Ph.D.
Associate
Boston, MA
+1 617 646 1651
Email

Related Insights

Hybrid Conference

Intellectual Property Law Institute 2026 – California

October 19-20, 2026

San Francisco

Hybrid Conference

Intellectual Property Law Institute 2026 – New York

September 28-29, 2026

New York

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

13th Annual Summit for Women Leaders in Life Sciences Law

July 29-30, 2026

Boston

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Federal Circuit IP Blog

Federal Circuit Affirms Noninfringement Ruling in Hatch-Waxman Litigation Based on Claim Construction, Prosecution History Estoppel, and the Disclosure-Dedication Rule

June 26, 2026

European IP Blog

UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir

8 June 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP